共 6 条
[1]
HBV感染免疫耐受期孕妇应用替比夫定阻断母婴传播有效性及停药安全性的研究[J] 盛秋菊;丁洋;李佰君;白菡;张翀;韩超;樊耀昕;李艳伟;窦晓光; 中华肝脏病杂志 2016, 04
[2]
育龄期妇女及孕妇抗乙型肝炎病毒治疗策略[J] 窦晓光; 中华肝脏病杂志 2015, 11
[3]
Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model[J] Jia‐Horng Kao;Tarik Asselah;Xiao‐Guang Dou;Kamal Hamed Journal of Gastroenterology and Hepatology 2017,
[4]
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update[J] Paul Martin;Daryl T.-Y. Lau;Mindie H. Nguyen;Harry L.A. Janssen;Douglas T. Dieterich;Marion G. Peters;Ira M. Jacobson Clinical Gastroenterology and Hepatology 2015,
[5]
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real‐life practice[J] Hua Zhang;Calvin Q. Pan;Qiumei Pang;Ruihua Tian;Miaoe Yan;Xin Liu Hepatology 2014,
[6]
Reprint of: Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination[J] Xiaofeng Liang;Shengli Bi;Weizhong Yang;Longde Wang;Gang Cui;Fuqiang Cui;Yong Zhang;Jianhua Liu;Xiaohong Gong;Yuansheng Chen;Fuzhen Wang;Hui Zheng;Feng Wang;Jing Guo;Zhiyuan Jia;Jingchen Ma;Huaqing Wang;Huiming Luo;Li Li;Shuigao Jin;Stephen C. Hadler;Yu Wang Vaccine 2013,